No Data
Arcellx Inc's Anito-cel Shows Promising Efficacy in Treating Challenging Multiple Myeloma, Merits Buy Rating
There's Reason For Concern Over Arcellx, Inc.'s (NASDAQ:ACLX) Massive 28% Price Jump
Arcellx Insider Sold Shares Worth $1,840,053, According to a Recent SEC Filing
Cantor Fitzgerald Initiates Arcellx(ACLX.US) With Buy Rating
Cantor Fitzgerald analyst Rick Bienkowski initiates coverage on $Arcellx(ACLX.US)$ with a buy rating.According to TipRanks data, the analyst has a success rate of 12.5% and a total average return of -
Cantor Fitzgerald Initiates Arcellx at Overweight
CCORF Maintains Arcellx(ACLX.US) With Buy Rating, Maintains Target Price $85
CCORF analyst John Newman maintains $Arcellx(ACLX.US)$ with a buy rating, and maintains the target price at $85.According to TipRanks data, the analyst has a success rate of 39.0% and a total